retatrutide news today recency 3 glp-1 GLP-1 trends 2025: real-world data, patient outcomes & future therapies Today, we shared new data
Description
Scars are a necessary trade-off of removing skin they are permanent, but placed discreetly and fade significantly over 12 to 18 months
As a result, healthcare providers cannot routinely prescribe it as an FDA-approved medication
In clinical trials, participants taking the highest dose of orforglipron lost up to 15% of their body weight by week 72
They help us lower our blood sugar, slow our digestive system, and make us feel full
Observations from LVAD patients also suggest that while many experience normalization of LV chamber geometry, changes in the ECM and the ratio of LV wall thickness to LV wall radius may not return to normal 37
It represents a strategic evolution in therapeutic development, moving beyond single-target approaches to multi-receptor agonism
